Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Virtual colonoscopy outcomes

This article was originally published in The Gray Sheet

Executive Summary

An August BlueCross BlueShield Technology Evaluation Center tech assessment concludes that virtual colonoscopy as an alternative to colonoscopy fails to meet evidence criteria. Among reasons for the negative decision, TEC cites variable diagnostic performance across studies - ranging from sensitivities of 35% to 100% - likely due to interpreter experience and practitioner inconsistency in performing technical parts of the test. An April JAMA study by Peter Cotton, MD, Medical University of South Carolina, et al., also concluded that virtual colonoscopy is not ready for prime time (1"The Gray Sheet" April 19, 2004, p. 20)...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT020783

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel